Showing results (961-970 of 991) with videos related to
Sort By:
Pageof 100
Cancer Medicine|May 22, 2020
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessmentLucia Nogova, Christian Mattonet, Matthias Scheffler, et al.The Lancet. Haematology|May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trialStefanie Kreissl, Helen Goergen, Ina Buehnen, et al.Nature Genetics|December 27, 2011
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencingMitchell S Stark, Susan L Woods, Michael G Gartside, et al.Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.The Lancet. Oncology|February 4, 2021
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trialPeter Borchmann, Annette Plütschow, Carsten Kobe, et al.Contemporary Clinical Trials|September 24, 2020
Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trialElizabeth A Kobe, David Edelman, Phillip E Tarkington, et al.Lancet (London, England)|October 25, 2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study GroupPeter Borchmann, Helen Goergen, Carsten Kobe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2025
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 TrialJustin Ferdinandus, Helen Kaul, Alexander Fosså, et al.Cancer Cell|November 22, 2024
Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockadeHabib Hamidi, Yasin Senbabaoglu, Niha Beig, et al.Nature|February 5, 2025
IL-27 elicits a cytotoxic CD8<sup>+</sup> T cell program to enforce tumour controlBéatrice Bréart, Katherine Williams, Stellanie Krimm, et al.Pageof 100